Diagnostic test
PLM AFB DRUG SUSCEPTIBILITY
About test
What does PLM AFB DRUG SUSCEPTIBILITY measure?
This test evaluates the drug susceptibility of acid-fast bacilli (AFB) identified by PLM testing, commonly including organisms associated with tuberculosis. It assesses whether the detected bacteria may be susceptible or resistant to specific anti-mycobacterial medicines. A healthcare professional may order it to help guide treatment selection, investigate possible drug resistance, or monitor cases where standard therapy may not be effective.
This overview is educational. Use the recorded preparation, sample and lab-partner details below for collection guidance, and confirm any missing information before collection.
Choose a laboratory
Compare eligible lab partners
Prices, report times and availability are shown from the catalog records for each eligible partner.
Thyrocare
- Sample for analysis
- Confirm with the collection team
- Report time
- To be confirmed
Preparation and specimen requirements can vary by test and laboratory. Follow the instructions shown for your selected partner and any advice from your healthcare professional.